These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11078022)

  • 1. Synthetic oligonucleotides as RNA mimetics: 2'-modified Rnas and N3'-->P5' phosphoramidates.
    Egli M; Gryaznov SM
    Cell Mol Life Sci; 2000 Sep; 57(10):1440-56. PubMed ID: 11078022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide n3'-->p5' phosphoramidates and thio-phoshoramidates as potential therapeutic agents.
    Gryaznov SM
    Chem Biodivers; 2010 Mar; 7(3):477-93. PubMed ID: 20232321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
    Gryaznov SM
    Biochim Biophys Acta; 1999 Dec; 1489(1):131-40. PubMed ID: 10807003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Lloyd DH; Chen JK; Schultz RG; DeDionisio LA; Ratmeyer L; Wilson WD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5798-802. PubMed ID: 7541136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Winter H
    Nucleic Acids Res; 1998 Sep; 26(18):4160-7. PubMed ID: 9722635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3'-amino-2',4'-BNA: novel bridged nucleic acids having an N3'-->P5' phosphoramidate linkage.
    Obika S; Onoda M; Morita K; Andoh J; Koizumi M; Imanishi T
    Chem Commun (Camb); 2001 Oct; (19):1992-3. PubMed ID: 12240255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase inhibitors--oligonucleotide phosphoramidates as potential therapeutic agents.
    Gryaznov S; Pongracz K; Matray T; Schultz R; Pruzan R; Aimi J; Chin A; Harley C; Shea-Herbert B; Shay J; Oshima Y; Asai A; Yamashita Y
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):401-10. PubMed ID: 11563055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Oligonucleotide 2'-O-Alkyl N3'→P5' (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity.
    Martínez-Montero S; Rajwanshi VK; Pandey RK; De Costa NTS; Hong J; Beigelman L; Gryaznov SM; Pourshahian S
    Nucleic Acid Ther; 2023 Oct; 33(5):319-328. PubMed ID: 37638793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates.
    Matray TJ; Gryaznov SM
    Nucleic Acids Res; 1999 Oct; 27(20):3976-85. PubMed ID: 10497261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Schultz RG; Gryaznov SM
    Nucleic Acids Res; 1996 Aug; 24(15):2966-73. PubMed ID: 8760881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
    Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
    Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.
    Chen JK; Schultz RG; Lloyd DH; Gryaznov SM
    Nucleic Acids Res; 1995 Jul; 23(14):2661-8. PubMed ID: 7651827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and properties of 3'-amino-2',4'-BNA, a bridged nucleic acid with a N3'-->P5' phosphoramidate linkage.
    Obika S; Rahman SM; Song B; Onoda M; Koizumi M; Morita K; Imanishi T
    Bioorg Med Chem; 2008 Oct; 16(20):9230-7. PubMed ID: 18812260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA polymerase activity on synthetic N3'→P5' phosphoramidate DNA templates.
    Lelyveld VS; O'Flaherty DK; Zhou L; Izgu EC; Szostak JW
    Nucleic Acids Res; 2019 Sep; 47(17):8941-8949. PubMed ID: 31428779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zwitterionic oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Mignet N; Gryaznov SM
    Nucleic Acids Res; 1998 Jan; 26(2):431-8. PubMed ID: 9421496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates.
    Pruzan R; Pongracz K; Gietzen K; Wallweber G; Gryaznov S
    Nucleic Acids Res; 2002 Jan; 30(2):559-68. PubMed ID: 11788719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion of triplex formation by N3'-->P5' phosphoramidate modification: thermodynamic and kinetic studies.
    Torigoe H
    Nucleic Acids Res Suppl; 2001; (1):57-8. PubMed ID: 12836262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
    Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.